MedicarePartD.guide

A non-government resource built from CMS public data

emtricitabine-tenofovir on Blue Rx PDP Plus (S5593-002)

generic Truvada

Covered.

Tier 4 (non-preferred drug). No quantity limit.

25%
Patient pays / month, after deductible
25%
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated at a preferred retail pharmacy. Other covered strengths are listed below.

All 4 covered strengths and forms
FormTierPatient pays / monthLimits
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated425%None
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated425%None
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated525%None
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated425%None

Other HIV drugs on this plan

Verify with the plan before prescribing or filling. Member services: (800)290-3914. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5593-002